Bempedoic acid is a synthetic lipid-lowering medication that inhibits atp-citrate lyase. It is used to reduce low-density lipoprotein cholesterol in patients with hypercholesterolemia. The drug acts by blocking a hepatic enzyme that reduces intracellular cholesterol synthesis. Blocking this enzyme leads to increased activity of ldl receptors on the cell surface. The resulting removal of cholesterol from the bloodstream lowers circulating ldl levels. Bempedoic acid is administered orally and works independently of the mevalonate pathway.

Bempedoic acid is a novel non-statin medication used to lower cholesterol in patients with hypercholesterolemia. It acts by inhibiting atp-citrate lyase, an enzyme involved in the early steps of de novo cholesterol synthesis. By blocking this enzyme the drug reduces hepatic cholesterol production, prompting the up-regulation of ldl receptors on the liver surface. Increased ldl receptor activity enhances the clearance of circulating low-density lipoprotein particles from the bloodstream. The resulting reduction in plasma ldl cholesterol contributes to a lower risk of cardiovascular events. Bempedoic acid is administered orally and is selectively activated only in the liver, which confers a distinct pharmacological profile compared with other cholesterol-lowering agents. The liver-specific activation limits systemic exposure, leading to a lower incidence of certain muscle-related adverse effects observed with some other therapies. Pharmacodynamically the drug demonstrates dose-dependent lowering of triglycerides and modest increases in high-density lipoprotein cholesterol levels.

Bempedoic acid may cause joint pain in some patients. It can lead to elevated liver enzymes that require monitoring. Some users report nausea or mild gastrointestinal discomfort. The medication may increase uric acid levels and trigger gout attacks. Dizziness or lightheadedness can occur especially when standing up quickly. Blood tests are recommended periodically to assess cholesterol reduction and kidney function.

Some patients experience headache as a common side effect. Others may develop urinary tract infections. Elevated blood cholesterol levels have been reported in a minority of cases. Gout attacks can occur more frequently while using the drug. Joint pain and muscle stiffness are occasionally observed. Blood pressure may rise modestly in some individuals. Fatigue and mild nausea are also listed among reported adverse effects.